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Abstract
Background: Understanding changes in the ecology and epidemiology of dengue is important to ensure resource
intensive control programmes are targeted effectively as well as to inform future dengue vaccination strategies.
Methods: We analyzed data from a multicentre longitudinal prospective study of fever in adults using a nested test
negative case control approach to identify epidemiological risk factors for dengue disease in Singapore. From April
2005 to February 2013, adult patients presenting with fever within 72 h at selected public primary healthcare clinics
and a tertiary hospital in Singapore were recruited. Acute and convalescent blood samples were collected and used
to diagnose dengue using both PCR and serology methods. A dengue case was defined as having a positive
RT-PCR result for DENV OR evidence of serological conversion between acute and convalescent blood samples.
Similarly, controls were chosen from patients in the cohort who tested negative for dengue using the same
laboratory methods.
Results: The host epidemiological factors which increased the likelihood of dengue disease amongst adults in
Singapore were those aged between 21 and 40 years old (2 fold increase) while in contrast, Malay ethnicity was
protective (OR 0.57, 95%CI 0.35 to 0.91) against dengue disease. Spatial factors which increased the odds of
acquiring dengue was residing at a foreign workers dormitory or hostel (OR 3.25, 95 % CI 1.84 to 5.73) while
individuals living in the North-West region of the country were less likely to get dengue (OR 0.50, 95%CI 0.29 to 0.
86). Other factors such as gender, whether one primarily works indoors or outdoors, general dwelling type or floor,
the type of transportation one uses to work, travel history, as well as self-reported history of mosquito bite or
household dengue/fever were not useful in helping to inform a diagnosis of dengue.
Conclusions: We have demonstrated a test negative study design to better understand the epidemiological risk
factors of adult dengue over multiple seasons. We were able to discount other previously speculated factors such
as gender, whether one primarily works indoors or outdoors, dwelling floor in a building and the use of public
transportation as having no effect on one’s risk of getting dengue.
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Background
Globally, dengue is the most widespread arbovirus that
currently infects approximately 390 million people per
year [1]. There are four antigenically distinct dengue virus
serotypes (DENV-1, DENV-2, DENV-3 and DENV-4).
Although the majority of cases resolve uneventfully, in a
number of cases, progression to severe dengue or dengue
haemorrhagic shock can occur resulting in death. There is
no effective treatment for dengue. Currently, the mainstay
of dengue prevention strategy relies on surveillance
systems to allow early case detection, larval and breeding
site source reduction of the main vector Aedes aegypti
mosquito.
The epidemiology of dengue in Singapore evolved from
a childhood disease with significant morbidity and morta-
lity in the 1960s into a period of low dengue incidence
between 1974 and 1985 following the introduction of
vector source reduction, public health education and law
enforcement in the 1970s. Despite continued implemen-
tation of these control measures resulting in a national
Aedes spp House index (HI), which is a measure of the
percentage of houses positive for Aedes spp breeding,
below 1 %, Singapore has experienced a resurgence of
dengue since 1986 [2, 3]. The success of vector control
activities likely resulted in the reduction of herd immunity
in older age groups as well as a fall in force of infection
[4]. Dengue became a disease affecting primarily adults
with children being spared although serologic surveys
have shown that they remain highly susceptible [5]. Previ-
ous analysis of case notification data have also found that
the prevalence of dengue in women were lower than men
as indicated by a male to female disease ratio of 1.6:1 [3, 6,
7] It has been postulated that the reason for such a pattern
of dengue epidemiology could be due to a shift in dengue
transmission from the home to outside the home [2].
Understanding changes in the ecology and epidemiology
of dengue is important for development of more effective
control programs [8]. Mosquito control programmes are
resource intensive. In Singapore, it was estimated that
vector control cost approximately US$50 million per year
[9]. Evidence to guide the use and prioritisation of such
funds will be invaluable. Dengue being a mosquito-borne
disease exhibits demographic as well as spatial and tem-
poral variations in their distribution [10]. However, there
is a paucity of long term studies identifying epidemio-
logical risk factors for dengue transmission over multiple
years. Understandably most published work describing
such risk factors are based on dengue case notification
data (clinical and/or laboratory confirmed) from surveil-
lance systems and incidence rate derived from population
census [7, 11–13]. Such data and epidemiological analysis
have significant limitations. Firstly, it is impossible to
exclude selection bias resulting from differences between
cases that present to healthcare and those that do not.
Secondly, no surveillance system can capture all dengue
cases so misclassification of population denominators as
non-cases is a constant limitation. Thirdly, the time
element is often poorly unaccounted for although dengue
epidemiology is season dependent and the force of infec-
tion of dengue is known to have temporal variations [14].
The test negative study design has primarily been used
and validated to assess vaccine effectiveness [15, 16].
Controls are selected from individuals who also presented
to clinicians with similar symptoms to cases and hence
were tested for the same disease of interest but found to
be negative. In classic case control studies, controls are
routinely selected from patients presenting to the same
healthcare facility as cases but with a distinct condition
from the disease of the cases being studied. For case
control results to be valid, controls should belong to the
same source population from which cases are identified
[17]. They should be individuals who theoretically would
have been cases had they acquired the targeted disease or
condition of interest. Therefore, test negative controls
have significant advantages over classic controls. They
provide assurance as being from the same source popu-
lation as cases would have presented to healthcare and
would have been cases if their aetiology had been the
disease being studied.
In this paper, we analyzed data from a multicentre
longitudinal prospective study of fever in adults using a
nested test negative approach to identify epidemiological




From April 2005 to February 2013, adult patients
aged > = 18 years presenting with acute onset fever (> =
37.5 C) or a history of fever (> = 37.5C) within 72 h at
selected public primary healthcare clinics and a tertiary
hospital in Singapore were recruited. Details of the cohort
were published previously [18]. The epidemiological data
collected included home address region (as well as
dwelling type and floor level if living in multi-storey flat),
healthcare recruitment site, travel history in the past
2 weeks, nature of work and primary means of transpor-
tation to work (Table 1). There were three scheduled
visits: Visit 1 at 1–3 days post fever onset, Visit 2 at 4–7
days post fever onset and visit 3 during convalescence at
3–4 weeks post fever onset. Venous blood was collected
at each visit.
Laboratory diagnosis
Blood samples were used to diagnose dengue using both
PCR and serology methods. RT-PCR was used to detect
DENV RNA as previously described [19]. Results were
analyzed with the LightCycler software version 3.5.
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Reactions with high crossover point (Cp) or ambiguous
melting curve results were further analyzed by 2 %
agarose gel electrophoresis, to confirm the presence of
the correctly sized amplicon. Serology testing for IgM and
IgG antibodies against DENV was performed using com-
mercially available ELISAs (Panbio, Brisbane, Australia)
according to manufacturer’s instructions.
Definitions
To ensure high sensitivity and specificity thus minimiz-
ing bias from misclassification, cases and controls were
classified using strict laboratory criteria. A dengue case
was defined as having a positive RT-PCR result for
DENV OR evidence of serological conversion between
acute and convalescent blood samples. Similarly, con-
trols were chosen from patients in the cohort whom we
could be confident that they did not have dengue. This
was defined as having a negative RT-PCR result for DENV
OR no evidence of serological conversion between acute
and convalescent blood samples.
Statistical analysis
Variables percentage proportions between cases and
controls were calculated. Data with continuous variables
were compared using two tailed t-test. Multilevel regres-
sion analysis incorporating time by month and year was
used for multivariable analysis. First we developed a full
model of dengue which included all independent vari-
ables: predetermined age categories, gender, ethnicity,
home address region, country of birth, healthcare recruit-
ment site, past medical history, self-reported history of
past dengue infection, dwelling type, dwelling floor level,
travel history, nature of work, transportation to work,
self-reported history of mosquito bite, self-reported history
of household dengue and self-reported history of household
fever. Backward stepwise regression was performed to
Table 1 Characteristics of cases and controls
Variable Category Case Control
n % n %
Total 395 1308
Age group <21 13 3.3 140 10.7
21 to 30 130 32.9 396 30.3
31 to 40 97 24.6 238 18.2
41 to 50 76 19.2 235 18.0
51 to 60 55 13.9 197 15.1
61 and above 24 6.1 102 7.8
Gender (Female/Male) Female 142 35.9 503 38.5
Ethnicity Chinese 265 67.1 781 59.7
Malay 33 8.4 240 18.3
Indian 57 14.4 193 14.8
Other 40 10.1 94 7.2
Home address region SW 52 13.4 204 15.8
C 204 52.4 646 50.0
NW 62 15.9 264 20.4
NE 61 15.7 158 12.2
SE 10 2.6 20 1.5
Country of origin
(Singapore/Others)
Singapore 248 62.8 909 69.5
Healthcare
recruitment site
A 217 54.9 807 61.7
B 12 3.0 24 1.8
C 34 8.6 180 13.8
D 28 7.1 63 4.8
E 33 8.4 193 14.8









No 378 96.7 1235 95.0
Dwelling type Multistorey
public flats
291 73.7 1082 82.8
Multistorey
private flats
18 4.6 64 4.9





51 12.9 77 5.9
Dwelling floor level mean floor 6 4a 7 4a
Travel history (No/Yes) No 342 86.6 1101 84.3
Type of employment
(Indoor/Outdoor/Both)




Unemployed 90 22.8 269 20.7
Indoor & Public 90 22.8 410 31.6
Indoor & Private 24 6.1 84 6.5
Indoor & Walking 10 2.5 41 3.2
Table 1 Characteristics of cases and controls (Continued)
Outdoor & Public 37 9.4 108 8.3
Outdoor & Private 24 6.1 51 3.9
Outdoor & Walking 19 4.8 29 2.2
Both & Public 52 13.2 208 16.0
Both & Private 35 8.9 80 6.2












No 295 74.7 1076 82.6
aStandard Deviation
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identify independent predictor variables of dengue disease.
We fixed age and gender but other variables were only
retained in the model if P < 0.05. All statistical analysis was
performed using STATA, version 13. We estimated that a
sample size of 395 cases and 10 % exposed controls would
allow us to detect highest odds ratio (OR) < 1 of 0.4 and
smallest OR > 1 of 2, with α at 0.05 and β of 0.1.
Results
A total of 3246 patients were recruited for the prospec-
tive cohort study. 1508 were excluded because they were
RT-PCR negative and also did not return for the conva-
lescent visit 3. Another 35 patients were also excluded
as they were RT-PCR negative and did not demonstrate
IgG seroconversion despite being IgM positive at Visit 1.
The remaining 1703 patients fulfilled our case definitions
for cases and controls and were used for subsequent ana-
lysis (Fig. 1). Summary demographics and epidemiological
characteristics between the study cases and controls are
shown in Table 1. Overall, cases and controls were fairly
similar. The temporal distribution of study dengue cases
also resembled the national notification of dengue cases as
shown in Fig. 2.
In the full model where all variables were included,
statistically significant odds ratios for dengue disease
were found for housing type and healthcare recruitment
site variables only (Table 2). However, after backward
stepwise analysis where age and gender were fixed, only
ethnicity, home address region and housing type remained
as relevant variables in the model. Individuals aged
between 21 and 30 years (OR 2.12, 95 % CI 1.11 to 4.05)
and 21 to 40 years (OR 2.28, 95 % CI 1.16 to 4.47) were
found to have significantly higher odds of dengue disease
compared to those < 21 years. The point estimate OR in
individuals aged > 41 years showed a downward trend
signifying lower risk of dengue disease although the
95 % CI were not statistically significant. There was no
difference in odds of dengue by gender. Geographically,
apart from residents in the North West region of Singapore
who had a lower risk of dengue (OR 0.50, 95 % CI 0.29 to
0.86), the rest of the island had similar risk. Interestingly,
Malay ethnicity was found to be protective against dengue
Fig. 1 Consort diagram of cases and controls used in the study
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disease with an OR 0.57, 95 % CI 0.35 to 0.91 when
compared to Chinese ethnicity. We also found that in-
dividuals residing at foreign worker dormitory/hostels
were more likely to be diagnosed with having dengue
compared to those residing in multi-storey public flats
(OR 3.25, 95 % CI 1.84 to 5.73).
Discussion
The host epidemiological factors which increase the
likelihood of dengue disease amongst adults in Singapore
were found to be age, particularly if one was aged between
21 and 40 years old while in contrast, Malay ethnicity was
found to lower the odds of dengue disease. Spatial epi-
demiological factors which increased the risk of dengue
was residing at a foreign workers dormitory or hostel
while individuals living in the North West region of the
country had a lower risk of dengue. We also confirmed
that there were no differences in odds of dengue disease
by gender. Other factors such as whether one primarily
works indoors or outdoors, unemployed status, dwelling
type or floor, the type of transportation one uses to work,
travel history, as well as self-reported history of mosquito
bite or household dengue/fever were not useful in helping
to inform a diagnosis of dengue. We have demonstrated a
test negative control study design incorporating temporal
adjustment using multi-level analysis to better understand
the epidemiological risk factors of dengue over multiple
seasons.
Our results defined a clear and specific age group with
increased risk of dengue over the past 8 years in
Singapore. Individuals aged 21 to 40 years old have the
highest risk of acquiring the disease amongst adults.
This is likely to be the age group with the highest risk
for the whole population as serologic studies have
confirmed very low rates of infection in children com-
pared to adults [5, 20]. Furthermore, the point odds
ratios of dengue in age categories above 40 years
clearly showed a downward trend. This has important
implications for future roll out of a dengue vaccine. The
leading dengue vaccine candidate is a recombinant live,
attenuated, tetravalent dengue vaccine (Sanofi Pasteur)
which demonstrated overall efficacy of 56 · 5 % [21]. How-
ever, these results were based on trial cohorts composed
of children in settings with high paediatric dengue inci-
dences. Strategically, one would normally aim to deploy a
vaccine at an age before the highest risk of infection or
disease. Our epidemiological study show that if a dengue
vaccine were deployed during the first year of life, in a
setting with older age of first infection such as Singapore,
the benefits of the vaccine would not be detectable until
20 years later. Currently, we do not know if protection will
persist that long. A rise in median age of infection re-
ported in developing countries like Thailand, Vietnam and
anecdotally across Asia suggests that Singapore’s epidemi-
ology may not be unique in the near future [12, 22–25].
Furthermore, older age of dengue disease was also com-
monly reported in non-endemic subtropical regions in
Taiwan and China who have large seasonal outbreaks
following importation of the virus [13, 26]. Therefore, a
pre-school leaving or even an adult dengue vaccination
strategy may need to be considered as a more rational and
cost effective approach for these settings. The challenge is
there is unlikely to be efficacy data for adults in the near
future to help inform policy decisions. Hence any roll out
would require close monitoring to assess efficacy as well
as safety. In addition, adult vaccination strategies are re-
nowned to be logistically very difficult to implement and
achieve high coverage. This has been demonstrated in
countries where adult influenza and pneumococcal vacci-
nation programmes have been rolled out. For a vector
borne disease like dengue, high coverage to reduce the
reproductive number to < 1 should be an important target
to ensure herd protection in the population with the
ultimate objective of disease elimination.
Surveillance data routinely reports higher number of
dengue cases and clusters in the eastern and central
Fig. 2 Distribution of dengue study cases and national notification cases, 2005 to 2013
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Table 2 Multilevel logistic regression analysis of dengue epidemiological risk factors
Variable Category Full model Stepwise model
OR 95 % CI AOR 95%CI
Gender Female 1.00 1.00
Male 1.05 0.72 to 1.53 0.95 0.70 to 1.31
Age Group < 21 1.00 1.00
21 to 30 2.56 1.24 to 5.29 2.12 1.11 to 4.05
31 to 40 3.01 1.39 to 6.53 2.28 1.16 to 4.47
41 to 50 2.53 1.17 to 5.47 1.83 0.92 to 3.62
51 to 60 2.35 1.04 to 5.34 1.62 0.79 to 3.31
61 and
above
1.68 0.63 to 4.51 1.18 0.51 to 2.72
Ethnicity Chinese 1.00 1.00
Malay 0.47 0.28 to 0.79 0.57 0.35 to 0.91
Indian 0.69 0.43 to 1.12 0.73 0.47 to 1.14




Central 0.63 0.28 to 1.39 0.65 0.42 to 1.02
North-west 0.38 0.15 to 0.98 0.50 0.29 to 0.86
North-east 0.74 0.32 to 1.77 1.20 0.71 to 2.03
South-east 1.21 0.36 to 4.12 1.25 0.44 to 3.54
Housing type Multistorey public flats 1.00 1.00
Multistorey private flats 0.80 0.37 to 1.73 0.73 0.35 to 1.52
Landed houses 0.99 0.28 to 3.55 1.44 0.82 to 2.55
Foreign workers
dormitory/hostel
3.03 1.51 to 6.06 3.25 1.84 to 5.73
Country of origin Singapore 1.00
Others 0.92 0.61 to 1.38
Healthcare recruitment site A 1.00
B 4.27 1.15 to 15.95
C 0.65 0.24 to 1.74
D 3.60 1.52 to 8.54
E 1.61 0.69 to 3.76
F 2.38 1.08 to 5.26
Self-reported history of past
dengue infection
No 1.00





Yes 0.58 0.34 to 0.99
Dwelling floor level Level 1 1.00
Every 1 level up 0.95 0.91 to 0.99
Travel history No 1.00
yes 0.87 0.55 to 1.37
Type of employment (Indoor/Outdoor/Both)




Indoor & Public 0.51 0.31 to 0.82
Indoor & Private 0.87 0.42 to 1.80
Indoor & Walking 0.70 0.28 to 1.78
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regions of Singapore [27]. Our analysis suggests that this
is probably an artefact of higher population densities in
these regions than actual higher dengue transmission.
We postulate that our finding of lower risk of dengue in
the North West region compared to the rest of the
island could also be attributed to the difference in level
of urbanization with subsequent variations in mosquito
vector species. The North West region of Singapore is
significantly less developed than the rest of the island
with large areas of forests still present. This would count
against the main vector of dengue, the Aedes Aegypti
species which is known to thrive in urban settings rather
than forested areas [28–31]. Unfortunately, we do not
have vector surveillance data to verify this and cannot
rule out other factors influencing spatial dengue risk.
We did find the odds of dengue disease to be more than
3 times higher in individuals living at foreign workers
dormitories or hostels compared to multi-storey public
flats where the majority of the local population resides.
Such settings could be high-risk areas for dengue
epidemics. Dengue transmission has been shown to vary
at the neighbourhood level within an urban setting in
Thailand [32]. Therefore, the densely occupied nature of
such dormitories or hostels in combination with low
herd immunity since a significant proportion of foreign
workers come from countries where dengue is not
endemic may be the reason for this. However, the workers
mostly work at construction sites and these have been
known to be high risk areas by authorities with mosquito
breeding found in about 10 % of sites inspected in 2013
[33]. Singapore has introduced tough legislation for guilty
contractors including stop-work orders, prosecution in
court and requirements to employ environmental con-
trol officer at large construction sites. It is difficult to
disentangle the actual site of dengue infection for this
cohort although individuals with dengue during the
highly infectious fever phase are more likely to be resting
at home. Strategies including both educational and source
reduction activities targeted at occupants as well as
owners of foreign worker residential sites may need to be
considered as part of public health efforts to control
dengue.
We were not able to identify any difference in odds of
dengue disease by factors such as gender, working out-
doors, being unemployed and type or level of dwelling.
Previous studies have suggested that dengue transmis-
sion in Singapore have shifted to outside the home
environment based on a jump in seroprevalence from
1 % in < 6 years old to about 7 % in 6 to 15 years which
is the age for formal schooling in Singapore [5]. Similarly,
it was also hypothesized that lower reported females
incidence could be explained by the same dynamics when
factoring differences in male and female proportions in
the workforce [6]. However, the pediatric seroprevalence
data did not have participants older than 15 years and
participants were recruited from a single hospital setting.
Large seroprevalence studies carried out in adults > 18
years old have shown that > 5 % increases in seropreva-
lence for 5 to 10 year age categories should be expected
[20, 34]. Gender differences in health seeking behaviour
and employment rates where producing a medical certifi-
cate is a requirement if one is unwell in Singapore could
have accounted for dengue gender variations found in
routine notification data. Since our controls were indivi-
duals who also presented to healthcare but tested negative
for dengue, our results were not vulnerable to these biases.
Furthermore, an adult serologic survey using samples
from a representative National Health Survey also did not
find that those who spent more time at home e.g. home-
maker or retired as being more likely to be positive for
recent dengue infection [34]. Outbreak reports using
notification data from the two large outbreaks (2005 and
Table 2 Multilevel logistic regression analysis of dengue epidemiological risk factors (Continued)
Outdoor & Public 0.70 0.35 to 1.41
Outdoor & Private 1.41 0.63 to 3.11
Outdoor & Walking 0.68 0.24 to 1.91
Both & Public 0.68 0.38 to 1.21
Both & Private 0.43 0.19 to 0.98












Yes 1.22 0.83 to 1.80
Figures in bold are statistically significant, P < 0.05
OR Odds Ratio, AOR Adjusted Odds Ratio, CI Confidence Interval
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2007) covered by the study period had conflicting reports
of increased risk of dengue by dwelling types [7]. The
scarcity of landed properties in Singapore makes landed
properties an important socioeconomic profile which may
affect health service seeking behaviour and access. Our
study design using robust controls confirmed that the type
and floor level one resides in does not influence one’s risk
of dengue disease. This lends support to the homogenous
success of national vector control activities and the known
significant vertical flight range of the Aedes mosquito [35].
Clinically, we were able to confirm that self-reported
history of mosquito bite or household dengue/fever and
travel history elicited during consultations were not
useful in predicting a diagnosis of dengue amongst febrile
patients, confirming the known challenges in clinical
dengue diagnosis. Interestingly, we did identify Malay
ethnicity as being almost 40 % less likely to have dengue
compared to Chinese ethnicity amongst adults presenting
with fever. Serologic surveys support this finding, with
Malay ethnicity identified as the ethnic group with the
lowest seropositivity [20, 34]. A genetic predisposition to
dengue fever or severe dengue is suspected and studies in
Vietnam and Cuba have found a possible role for HLA
class 1 allele [36, 37]. A recent study in neighbouring
Malaysia which has a similar ethnic mix to Singapore
identified HLA-B*13 and HLA-B*18 as being associated
with dengue susceptibility and protection respectively
amongst patients with Malay ethnicity.
In this study we were not able to account for the role
of dengue infection. We used febrile adults presenting to
healthcare with a confirmed diagnosis of dengue as a
proxy for dengue transmission. However, surveillance
notification data are also subject to the same limitation.
Although serologic surveys can identify dengue infection
especially seroprevalence, available tests are limited by
their ability to identify actual date of infection. We also
assumed that our study cohort was representative of
dengue epidemiology in Singapore. Comparing our inci-
dence to national notification data covering the same
period showed similar distribution which would support
our assumption (Fig. 2). We were not able to investigate
serotype specific differences which may be present in view
of known variations in viral competence. DENV-1 and
DENV-2 were the predominant circulating serotypes
during the study period.
Conclusions
Our results provided invaluable insights into deciphering
the epidemiology of adult dengue in urban settings. We
demonstrated the use of test negative controls which
minimized biases associated with notification data rou-
tinely used for studying dengue epidemiological risk
factors. In Singapore, the age group most likely to acquire
dengue disease was found to be between 21 to 40 years
but Malay ethnicity was found to be protective against
dengue. We also identified living in a foreign worker
dormitory/hostel as a significant epidemiological risk
factor for dengue disease. Spatially, the risk of dengue was
significantly lower in the North West region of Singapore
compared to the rest of the island possibly due to its lower
level of urbanization resulting in reduced Aedes Aegypti
prevalence. We confirmed that gender, employment, use
of public transportation, dwelling type as well as floor did
not affect one’s odds of getting dengue. Our findings have
important implications in informing clinical diagnosis of
adult dengue, prioritising vector control activities as well
as future roll out of a licensed dengue vaccine.
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